Secondary amyloidosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 50: | Line 50: | ||
*'''Rare disorders''' | *'''Rare disorders''' | ||
|- | |- | ||
| rowspan=" | | rowspan="6" align="center" style="background:#f0f0f0;" |'''Peripheral neuropathy causes''' | ||
| | | | ||
*'''Neurologic disorders''' | *'''Neurologic disorders''' | ||
| Line 57: | Line 57: | ||
*'''Inflammatory disorders''' | *'''Inflammatory disorders''' | ||
|- | |- | ||
| | | | ||
*'''Toxins''' | *'''Toxins''' | ||
Revision as of 20:07, 4 November 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.
Differentiating Amyloidosis from other Diseases
Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.
| Differential diagnosis of secondary amyloidosis | |
| Nephrotic syndrome causes |
|
| |
| |
| |
| Hepatosplenomegaly causes |
|
| |
| |
| |
| |
| Peripheral neuropathy causes |
|
| |
| |
| |
| |
| |